Patients will take Maraviroc 300 mg (two 150 mg tablets) PO b.i.d. (without regard to food ) if the co-administered PI is Fosamprenavir or Tipranavir The duration of the study is 5-7 years for PHI patients and 2.5 - 7.5 years for CHR patients.